UPDATED Apr 23, 2024
Financially strong companies with expected earnings growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NOVO B | kr.878.70 | 0.8% | 58.2% | kr.4.0t | kr.904.20 | PE46.8x | E14.7% | 1.1% | Pharmaceuticals & Biotech | ||
ALK B | kr.126.50 | 0.2% | 51.9% | kr.28.5b | kr.131.50 | PE57.6x | E22.9% | 0% | Pharmaceuticals & Biotech | ||
FLS | kr.352.00 | -1.1% | 35.1% | kr.20.0b | kr.370.63 | PE29.5x | E20.8% | 1.1% | Capital Goods |